CN100387283C - Chinese traditional medicine for treating diabetes retinopathy - Google Patents
Chinese traditional medicine for treating diabetes retinopathy Download PDFInfo
- Publication number
- CN100387283C CN100387283C CNB2004100924078A CN200410092407A CN100387283C CN 100387283 C CN100387283 C CN 100387283C CN B2004100924078 A CNB2004100924078 A CN B2004100924078A CN 200410092407 A CN200410092407 A CN 200410092407A CN 100387283 C CN100387283 C CN 100387283C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- treatment
- medicine
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to Chinese traditional medicine of tang mu ning for treating diabetes retinopathy, which is prepared from the following components by the weight part ratio: 10 to 30 parts of astragalus root, 10 to 20 parts of ophiopogon root, 10 to 30 parts of kudzuvine root, 10 to 30 parts of barbary wolfberry fruit and 10 to 30 parts of red sage root. The traditional Chinese medicine can have good treating effects by benefiting Qi, nourishing yin and promoting blood circulation.
Description
Technical field
The present invention relates to the Chinese medicine that a kind of treatment of diabetic retinopathy becomes.
Technical background:
Diabetic renal papillary necrosis is one of diabetes three big complication, account for the 50%-60% of diabetic, and sickness rate increases along with the growth of the course of disease; Diabetic renal papillary necrosis has become the one of the main reasons of blinding, and blind rate is increasing year by year; The probability that diabetes cause losing one's sight is 25 times of non-diabetic, and diabetic renal papillary necrosis accounts for 80% of diabetes blinding at least.Therefore, how the active treatment diabetic renal papillary necrosis is one of pendulum urgent task in face of the Chinese and western medicine medical personnel.In recent years, the Chinese medicine primary disease demonstrates remarkable advantages, more and more is subject to people's attention.The Chinese medicine that existing treatment of diabetic retinopathy becomes is a lot, is basically to set forth one's views with " hepatic and renal YIN deficiency ", and be method with " liver and kidney tonifying ".The achievement in research that present existing treatment of diabetic retinopathy becomes, as Chinese patent application number 02132895.1, announced a kind of " medicine that treatment of diabetic retinopathy becomes and preparation method thereof ", be to be raw material with 23 Chinese herbal medicine such as Fructus Crataegi, Semen Cassiae, Cortex Phellodendri, Fructus Lycii, Semen Cuscutae, the Radix Astragali, Radix Codonopsis, the Radix Rehmanniae, pollen, Herba Dendrobii, the Rhizoma Pinelliae, Rhizoma Dioscoreae, Rhizoma Atractylodis, Fructus Aurantii, Semen Plantaginiss, making eye bright with air making-up and spleen enlivening, YIN nourishing is principle, comes treatment of diabetic retinopathy to become; But less because of the power of its blood circulation promoting and blood stasis dispelling, to the oculopathy that pathogen usually intruding into collateral in protracted disease causes, still dislike not enough.
Summary of the invention:
Purpose of the present invention provides the Chinese medicine that a kind of treatment of diabetic retinopathy becomes.
The present invention is achieved through the following technical solutions:
1. make by following materials of weight proportions medicine:
Radix Astragali 10-30 part, Radix Ophiopogonis 10-20 part, Radix Puerariae 10-30 part, Fructus Lycii 10-30 part and Radix Salviae Miltiorrhizae 10-30 part.
2. the weight proportion of each crude drug is: Radix Astragali 15-25 part, Radix Ophiopogonis 10-15 part, Radix Puerariae 15-25 part, Fructus Lycii 10-20 part and Radix Salviae Miltiorrhizae 10-25 part.
3. the weight proportion of each crude drug is: 20 parts of 20 parts of the Radixs Astragali, 15 parts of Radix Ophiopogonis, 20 parts of Radix Puerariaes, 20 parts of Fructus Lycii and Radix Salviae Miltiorrhizaes.
Solution of the present invention is based on understanding and the Therapeutic Principle of motherland's medical science to " quenching one's thirst ", " blurring of vission ", with reference to the modern pharmacology achievement in research, comes treatment of diabetic retinopathy to become.According to theory of Chinese medical science, the primary disease pathogenesis mainly is that with the passing of time diabetes do not heal, deficiency of both QI and YIN, and the handsome blood of the deficiency of vital energy is unable, produces blood stasis, thereby impels the generation of diabetic renal papillary necrosis.So treatment is a basis with QI invigorating, yin nourishing, is mark to invigorate blood circulation.Radix Astragali QI invigorating among the side of the present invention, Radix Ophiopogonis, Radix Puerariae, Fructus Lycii YIN nourishing and the production of body fluid promoting, Radix Salviae Miltiorrhizae is invigorated blood circulation.Blood is lived then can blood stasis dispelling, and blood stasis must go, and could regenerate in cloudy Tianjin.The capable Tianjin of blood cloth, the passages through which vital energy circulates of eye is unobstructed, and order gets qi-blood-body fluid and supports, and looks the function that thing is distinguished color and recover it.
Advantage of the present invention is that the effect that treatment of diabetic retinopathy becomes is obvious.Reason is that the present invention is on the basis of traditional Chinese medical science tradition method of treatment, according to the theory of " eliminating blood stasis to promote regeneration of blood ", has added the medicine of " invigorating blood circulation ", and curative effect is obviously improved.
For showing the curative effect of Chinese medicine of the present invention, do clinical observation through Institute of Hypertension and Diabetes, Hebei Academy of Chinese Medicine, the result is as follows:
Treatment simple type diabetic renal papillary necrosis 22 examples, the glycemic control situation: produce effects 10 examples, effective 7 examples, invalid 3 examples worsen 2 examples, and total effective rate 77.3% illustrates that this medicine has certain blood sugar reducing function.The vision situation of change: in 44 eyes of 22 examples, 3 eyes of vision produce effects person, effective 28 eyes, invalid 13 eyes, total effective rate is 70.4%.The optical fundus situation of change: in 44 eyes of 22 examples, 9 eyes of optical fundus produce effects, effective 24 eyes, invalid 9 eyes worsen 2 eyes, and total effective rate is 75%.
Embodiments of the present invention are as follows:
| Component | Implement 1 | Implement 2 | Implement 3 | Implement 4 | Implement 5 | Implement 6 | Implement 7 |
| The Radix Astragali | 10g | 20g | 30g | 15g | 18g | 25g | 20g |
| Radix Ophiopogonis | 20g | 15g | 10g | 15g | 12g | 10g | 15g |
| Radix Puerariae | 10g | 20g | 30g | 15g | 18g | 25g | 20g |
| Fructus Lycii | 30g | 20g | 10g | 20g | 15g | 10g | 20g |
| Radix Salviae Miltiorrhizae | 10g | 20g | 30g | 10g | 18g | 25g | 20g |
The production method that above-mentioned each component is made Chinese medicine of the present invention is:
Get the Radix Astragali, Radix Ophiopogonis, Radix Puerariae, Fructus Lycii, Radix Salviae Miltiorrhizae, mix, be soaked in water 2-4 hour, extract 3 times with the decocting extraction method, each time all used slow fire boiling 1-2 hour, with 3 decocting liquid mixing, concentrated, dry, promptly obtains finished product.
Utilize respectively component of the present invention, make said any oral medicine dosage form on the pharmaceutics of Chinese drugs, all can play same effect.
Claims (3)
1. the Chinese medicine that becomes of a treatment of diabetic retinopathy, it is made by following materials of weight proportions medicine: Radix Astragali 10-30 part, Radix Ophiopogonis 10-20 part, Radix Puerariae 10-30 part, Fructus Lycii 10-30 part and Radix Salviae Miltiorrhizae 10-30 part.
2. the Chinese medicine that treatment of diabetic retinopathy according to claim 1 becomes, wherein the weight proportion of each crude drug is: Radix Astragali 15-25 part, Radix Ophiopogonis 10-15 part, Radix Puerariae 15-25 part, Fructus Lycii 10-20 part and Radix Salviae Miltiorrhizae 10-25 part.
3. the Chinese medicine that treatment of diabetic retinopathy according to claim 1 and 2 becomes, wherein the weight proportion of each crude drug is: 20 parts of 20 parts of the Radixs Astragali, 15 parts of Radix Ophiopogonis, 20 parts of Radix Puerariaes, 20 parts of Fructus Lycii and Radix Salviae Miltiorrhizaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100924078A CN100387283C (en) | 2004-12-13 | 2004-12-13 | Chinese traditional medicine for treating diabetes retinopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100924078A CN100387283C (en) | 2004-12-13 | 2004-12-13 | Chinese traditional medicine for treating diabetes retinopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1788776A CN1788776A (en) | 2006-06-21 |
| CN100387283C true CN100387283C (en) | 2008-05-14 |
Family
ID=36787019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100924078A Expired - Fee Related CN100387283C (en) | 2004-12-13 | 2004-12-13 | Chinese traditional medicine for treating diabetes retinopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100387283C (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893540B (en) * | 2012-12-25 | 2016-10-05 | 北京中研同仁堂医药研发有限公司 | A kind of Chinese medicine composition controlling IGT and preparation method thereof |
| CN104189146B (en) * | 2014-07-25 | 2016-09-21 | 北京汉典制药有限公司 | A kind of traditional Chinese drug inspissation watered pill and application thereof |
| CN105833064A (en) * | 2016-03-25 | 2016-08-10 | 刘娟 | Eyesight-improving decoction for treating diabetic retinopathy |
| CN108186876A (en) * | 2018-03-14 | 2018-06-22 | 杨蕊 | A kind of Chinese medicine composition for having the function of to reduce blood glucose and preparation method thereof |
| CN111494459A (en) * | 2020-05-20 | 2020-08-07 | 成都中医药大学 | Pharmaceutical composition for treating diabetic retinopathy and preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1061910A (en) * | 1991-11-27 | 1992-06-17 | 姚昌礼 | Process for preparing diabetes medicine-ketangping |
| CN1302643A (en) * | 2000-12-15 | 2001-07-11 | 陈月秋 | Prescription for treating diabetes |
-
2004
- 2004-12-13 CN CNB2004100924078A patent/CN100387283C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1061910A (en) * | 1991-11-27 | 1992-06-17 | 姚昌礼 | Process for preparing diabetes medicine-ketangping |
| CN1302643A (en) * | 2000-12-15 | 2001-07-11 | 陈月秋 | Prescription for treating diabetes |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1788776A (en) | 2006-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103690783B (en) | Chinese medicine preparation being used for the treatment of diabetes and preparation method thereof | |
| CN101675982A (en) | Traditional Chinese medicine composition for warming heart yang and reducing phlegm and absorbing clots | |
| CN102614442B (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
| CN102370878B (en) | Chinese medicinal oral preparation for treating aphthous stomatitis | |
| CN104324355A (en) | Traditional Chinese medicine composition for treating peripheral neuropathy caused by diabetes | |
| CN103599496B (en) | Traditional Chinese medicine for treatment of chronic gastritis | |
| CN102940785B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN101204481A (en) | Chinese traditional medicine for chronic nephritis | |
| CN104922299A (en) | Traditional Chinese medicine healthcare oral liquid used for preventing and treating diabetic retinopathy | |
| CN100387283C (en) | Chinese traditional medicine for treating diabetes retinopathy | |
| CN102526496B (en) | Traditional Chinese medicine composition for treating fire excess from yin deficiency type sleepless night sweating symptoms, and preparation method of traditional Chinese medicine composition | |
| CN103142914B (en) | Traditional Chinese medicine for lowering blood sugar | |
| CN106361918A (en) | Traditional Chinese medicine patch for treating deficiency of kidney-yang | |
| CN105963450A (en) | Traditional Chinese medicine composition for treating dizziness and faintness | |
| CN113041324A (en) | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type diabetic nephropathy and preparation method thereof | |
| CN103656459B (en) | A kind of Chinese medicine for the treatment of deficiency of both lung and spleen syndrome cough | |
| CN102988890A (en) | Pure Chinese medicine preparation for treating chloasma | |
| CN103550437B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN103432422B (en) | Traditional Chinese medicine for treating chronic gastritis | |
| CN103550745B (en) | Traditional Chinese medicine composition for treating hypotension and preparation method of traditional Chinese medicine composition for treating hypotension | |
| CN103784865A (en) | Chinese herbal medicine for treating palpitation due to insufficiency heart qi, deficiency of yin and stagnation of liver qi | |
| CN1273851A (en) | Chinese medicine for treating intraocular hemorrhage | |
| CN101912476A (en) | Chinese medicinal herbs for treating female menorrhagia disease | |
| CN101574390B (en) | Chinese medicinal composition for treating irregular menstruation | |
| CN105381333A (en) | Traditional Chinese medicine composition with effects of treating spleen-kidney Yang deficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |